RESOQUINE

This brand name is authorized in Nigeria.

Active ingredients

The drug RESOQUINE contains one active pharmaceutical ingredient (API):

1	Chloroquine UNII 6E17K3343P - CHLOROQUINE PHOSPHATE
	Chloroquine binds to and alters the properties of DNA. Chloroquine also binds to ferriprotoporphyrin IX and this leads to lysis of the plasmodial membrane. In acute attacks of malaria, it interrupts erythrocytic schizogony of the parasite.
	Read more about Chloroquine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-4350	Solution for injection	Resoquine Injection INJ_SOL 40 mg/mL 30 mL	Solution for injection in 30-mL vial Each mL contains: Chloroquine Phosphate 64.5 mg equiv. to Chloroquine base 40 mg	27/05/2021
A11-100100	Tablet	Resoquine Tablet TAB 155 mg	Each tablet contains: Chloroquine Phosphate 250 mg equiv. to Chloroquine base 155 mg	07/05/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P01BA01	Chloroquine	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BA Aminoquinolines
Discover more medicines within P01BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-4350, A11-100100